Marinus Pharma Stock Price (NASDAQ:MRNS)

Add to My Stocks
$7.94 $0.38 (5.03%) MRNS stock closing price Sep 19, 2018 (Closing)
Prev Close* : $7.56
Market Cap:
$306.37M
Day Low: $7.57
52 Week Low: $3.31
Open: $7.57
Volume: -
Day High: $8.08
52 Week High: $9.87
Dividend:
0.00

Latest Stock Market News

Latest Articles

Marinus Pharma News - From Partners

MRNS Stockcharts

View MRNS PE ratio, PS ratio stocks charts and compare with peers.
MRNS Chart
Note: Compare Marinus Pharma stock price history with the index and industry peers.

Marinus Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Marinus Pharma Returns

ROE
(return on equity)

Marinus Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

MRNS Industry Peers

Company Price Change (%)
Affirmed (AFMD)4.70.35 (8.05%)
Corbus Pharmaceuticals (CRBP)5.180.08 (1.57%)
Neon Therapeutc (NTGN)7.810.91 (10.44%)
Glaxosmithkline (GSK)39.550.08 (0.2%)
Eisai (ESALY)94.221.61 (1.68%)
Amneal Pharmact (AMRX)23.80.34 (1.45%)
Pernix Therapeutics (PTX)0.850.05 (5.56%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Marinus Pharmaceuticals Inc Stock News - Partner Headlines

Marinus Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-18.89M-28.64M-24.85M-10.83M-5.26M
Total Operating Expense19.03M28.23M24.42M11.92M5.37M
View Marinus Pharma income statement
balance sheet20172016201520142013
Total Assets60.67M31.44M59.66M50.21M11.82M
Total Liabilities2.66M9.96M12.74M9.05M2.36M
Shareholders Equity58M21.47M46.92M41.15M9.45M
View Marinus Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.9M-2.59M2.72M-1.54M
Net Cash from (used by) Operating Activities-18.81M-24.76M-20.12M-8.58M-6.62M
Increase (Decrease) in Prop Plant And Equipment-0.45M-0.64M--0.03M-0.01M
View Marinus Pharma cash flow statement

Marinus Pharma Stock Message Board

As of last trading day, Marinus Pharma stock price was $7.94. Stock price or share price can be used to find the total market value of a company. Marinus Pharma market cap stands at $306.37M as of Sep 19, 2018. A value investor must look at the fundamentals of a stock, and perform Marinus Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Marinus Pharma stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Marinus Pharma is worth a lot, it will most likely be reflected in an inflated Marinus Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 1,814,288 on the last trading day, as is evident from Marinus Pharma stock chart, and MRNS stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Marinus Pharma stock dividend was 0.00 during the last quarter. Marinus Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.